Sarah Gheuens - Net Worth and Insider Trading
Sarah Gheuens Net Worth
The estimated net worth of Sarah Gheuens is at least $2 Million dollars as of 2024-12-27. Sarah Gheuens is the Chief Medical Officer of Agios Pharmaceuticals Inc and owns about 43,736 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $2 Million. Details can be seen in Sarah Gheuens's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sarah Gheuens has not made any transactions after 2024-07-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sarah Gheuens
Sarah Gheuens Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sarah Gheuens owns 2 companies in total, including Agios Pharmaceuticals Inc (AGIO) , and Viridian Therapeutics Inc (VRDN) .
Click here to see the complete history of Sarah Gheuens’s form 4 insider trades.
Insider Ownership Summary of Sarah Gheuens
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals Inc | 2024-07-01 | Chief Medical Officer |
| VRDN | Viridian Therapeutics Inc | 2023-09-21 | director |
Sarah Gheuens Latest Holdings Summary
Sarah Gheuens currently owns a total of 1 stock. Sarah Gheuens owns 43,736 shares of Agios Pharmaceuticals Inc (AGIO) as of July 1, 2024, with a value of $2 Million.
Latest Holdings of Sarah Gheuens
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGIO | Agios Pharmaceuticals Inc | 2024-07-01 | 43,736 | 34.37 | 1,503,206 |
Holding Weightings of Sarah Gheuens
Sarah Gheuens Form 4 Trading Tracker
According to the SEC Form 4 filings, Sarah Gheuens has made a total of 6 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 3,705 shares on July 1, 2024, which brought Sarah Gheuens around $162,464.
Insider Trading History of Sarah Gheuens
- 1
Sarah Gheuens Trading Performance
Sarah Gheuens Ownership Network
Sarah Gheuens Owned Company Details
What does Agios Pharmaceuticals Inc do?
Who are the key executives at Agios Pharmaceuticals Inc?
Sarah Gheuens is the Chief Medical Officer of Agios Pharmaceuticals Inc. Other key executives at Agios Pharmaceuticals Inc include Principal Accounting Officer Washburn Theodore James Jr. , Chief Legal Officer James William Burns , and Chief Financial Officer Cecilia Jones .
Agios Pharmaceuticals Inc (AGIO) Insider Trades Summary
Over the past 18 months, Sarah Gheuens made 6 insider transaction in Agios Pharmaceuticals Inc (AGIO) with a net sale of 12,193. Other recent insider transactions involving Agios Pharmaceuticals Inc (AGIO) include a net sale of 10,188 shares made by Washburn Theodore James Jr. , a net sale of 35,912 shares made by James William Burns , and a net sale of 64,534 shares made by Brian Goff .
In summary, during the past 3 months, insiders sold 42,724 shares of Agios Pharmaceuticals Inc (AGIO) in total and bought 0 shares, with a net sale of 42,724 shares. During the past 18 months, 295,320 shares of Agios Pharmaceuticals Inc (AGIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 295,320 shares.
Agios Pharmaceuticals Inc (AGIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Agios Pharmaceuticals Inc Insider Transactions
Sarah Gheuens Mailing Address
Above is the net worth, insider trading, and ownership report for Sarah Gheuens. You might contact Sarah Gheuens via mailing address: C/o Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
